Novavax
NVAX
#5751
Rank
A$1.69 B
Marketcap
A$10.40
Share price
0.73%
Change (1 day)
-19.16%
Change (1 year)

Novavax (NVAX) Fails to deliver data

Key failure to deliver metrics for Novavax:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Novavax (NVAX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Novavax (NVAX) - since 2019

Volume in USD (price x number of shares), data since 2019

Novavax (NVAX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$53.84 M-64.08%
2024A$0.14 B-61.61%
2023A$0.39 B-2.97%
2022A$0.40 B0.26%
2021A$0.40 B22.77%
2020A$0.32 B531.98%
2019A$51.73 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Agenus
AGEN
A$0.39 MA$3.49 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.3 MA$22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.89 MA$4.32 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.58 MA$4.51 M๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$21.14 MA$0.11 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$24.63 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$18.77 MA$0.12 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
A$1.96 MA$6.74 M๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$72.01 MA$0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
A$7.65 MA$11.96 M๐Ÿ‡บ๐Ÿ‡ธ USA